RxDoctor Payments Data

Jacques Hacquebord, MD

Hand Surgery · New York, NYNPI 1407098163

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,261 of the $22,388 with a category attached, or 63.7%. 19 manufacturers reported payments, led by Synthes USA Products LLC at 33.5% of the total. Reporting peaked in 2020 at $8,075 and has fallen 76.1% since, to $1,932 in 2025.

$22,388in general payments, 2019–2025

Across 88 payments — averaging $254.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes USA Products LLC$8K
  • Checkpoint Surgical, Inc$6K
  • Medical Device Business Services, Inc.$5K
  • Johnson & Johnson$653
  • Integra Lifesciences Corporation$521
  • Stryker$370
  • plus $2K from 13 others
$24,025in research payments, 2019–2025

Across 1 payment — averaging $24,025 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medartis Inc.$24K

What the payments were for

  • Consulting fees$14,26164%
  • Speaking & faculty fees$1,0505%
  • Travel & lodging$2,40011%
  • Food & beverage$4,67821%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,388 in reported general payments places this provider in the 85th percentile of 178 hand surgery providers in New York.

See all hand surgery providers in New York

Medicare billing

Part B allowed, 2024
$128,409
Medicare patients
288
Services billed
997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin16$110

Paid to pharmacies, not to this prescriber.

Other hand surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →